LCTX
Lineage Cell Therapeutics Inc

7,797
Mkt Cap
$395.06M
Volume
2.09M
52W High
$2.09
52W Low
$0.3651
PE Ratio
-9.47
LCTX Fundamentals
Price
$1.73
Prev Close
$1.82
Open
$1.80
50D MA
$1.58
Beta
1.11
Avg. Volume
1.8M
EPS (Annual)
-$0.093
P/B
8.16
Rev/Employee
$123,363.64
Loading...
Loading...
News
all
press releases
Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates
Lineage Cell (LCTX) delivered earnings and revenue surprises of -550.00% and +40.34%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7h ago
News Placeholder
More News
News Placeholder
Strength Seen in Wave Life Sciences (WVE): Can Its 11.4% Jump Turn into More Strength?
Wave Life Sciences (WVE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·28d ago
News Placeholder
Lineage Cell (LCTX) Reports Q2 Loss, Beats Revenue Estimates
Lineage Cell (LCTX) delivered earnings and revenue surprises of +50.00% and +75.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Nuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates
Nuvation Bio (NUVB) delivered earnings and revenue surprises of 0.00% and +93.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Brookdale Senior Living (BKD) Reports Q2 Loss, Misses Revenue Estimates
Brookdale (BKD) delivered earnings and revenue surprises of -28.57% and -0.64%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates
Zacks·6mo ago
News Placeholder
Editas Medicine (EDIT) Reports Q1 Loss, Tops Revenue Estimates
Zacks·6mo ago
News Placeholder
5 Stocks Retail Investors Are Most Bearish On At Mid-Day
Disappointing retail earnings and concerns about bloated valuations are weighing down on retail sentiment toward some stocks.
Stocktwits·1y ago

Latest LCTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.